Carisma Therapeutics, Inc. (CARM)

NASDAQ: CARM · Real-Time Price · USD

0.1916

-0.0005 (-0.26%)

At close: Apr 4, 2025, 4:00 PM

0.1905

-0.0011 (-0.57%)

After-hours: Apr 4, 2025, 6:04 PM EDT

Carisma Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	19.63	14.92	9.83	-	-
Revenue Growth (YoY)	31.59%	51.71%	-	-	-
Cost of Revenue	-	74.13	56.62	34.39	-
Gross Profit	19.63	-59.21	-46.78	-34.39	-
Selling, General & Admin	22.14	29.53	9.38	6.41	5.09
Research & Development	59.67	-	-	-	23.29
Operating Expenses	81.81	29.53	9.38	6.41	28.38
Operating Income	-62.18	-88.73	-56.16	-40.79	-28.38
Interest Expense	-	-	-3.15	-	-
Interest & Investment Income	1.7	1.94	-	0.01	0.03
Other Non Operating Income (Expenses)	-	-0.08	-1.92	-	-
Pretax Income	-60.48	-86.88	-61.23	-40.78	-28.35
Net Income	-60.48	-86.88	-61.23	-40.78	-28.35
Net Income to Common	-60.48	-86.88	-61.23	-40.78	-28.35
Shares Outstanding (Basic)	41	34	2	1	1
Shares Outstanding (Diluted)	41	34	2	1	1
Shares Change (YoY)	23.66%	1475.33%	96.30%	1.95%	-
EPS (Basic)	-1.46	-2.59	-28.77	-37.62	-26.66
EPS (Diluted)	-1.46	-2.59	-28.77	-37.62	-26.66
Free Cash Flow	-60.04	-82.31	-9.78	-39.2	-27.45
Free Cash Flow Per Share	-1.45	-2.46	-4.59	-36.16	-25.82
Gross Margin	100.00%	-	-	-	-
Operating Margin	-316.72%	-594.75%	-571.10%	-	-
Profit Margin	-308.05%	-582.34%	-622.60%	-	-
Free Cash Flow Margin	-305.83%	-551.71%	-99.41%	-	-
EBITDA	-58.83	-85.89	-54.27	-40.11	-27.93
EBITDA Margin	-299.64%	-	-	-	-
D&A For EBITDA	3.35	2.84	1.89	0.68	0.45
EBIT	-62.18	-88.73	-56.16	-40.79	-28.38

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q